Grant: Operating Grant: Methamphetamine and related psychostimulant use

Methamphetamine/Amphetamine use disorder is a public health problem both in Canada and internationally and is associated with multiple morbidities (e.g., HIV infection, hepatitis, cardiac effects, family disruptions and prominent psychiatric consequences). Several harm reduction as well as psychological and pharmacological treatment options for supporting people using methamphetamine have been previously examined. Nonetheless, there is a lack of consensus over the most effective and acceptable harm reduction and treatment options. This study aims to review international experiences in both harm reduction and treatment (psychological and pharmacological) interventions aimed at people with methamphetamine/amphetamine use disorder and focus on and discuss Canadian circumstances where appropriate.